56.6
Aprea Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
30.2
FY23:
22.5
FY24:
23.6
FY25:
15.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.24
FY22:
0.00
FY23:
0.13
FY24:
0.40
FY25:
0.37
Total assets
Change from FY21 to FY25
millions USD
FY21:
56.8
FY22:
30.2
FY23:
22.7
FY24:
24.0
FY25:
15.9
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
7.32
FY22:
3.20
FY23:
4.39
FY24:
3.36
FY25:
2.76
(negative)
millions USD
FY21:
0
FY22:
0
FY23:
1.31
FY24:
1.31
FY25:
0.73
(positive)
Change from FY21 to FY25
millions USD
FY21:
49.5
FY22:
25.6
FY23:
17.0
FY24:
19.3
FY25:
12.4
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
56.8
FY22:
–
FY23:
22.7
FY24:
24.0
FY25:
15.9
All amounts in millions USD